Table 3.
Endoscopic treatment as a secondary prophylaxis of variceal bleeding in patients with cirrhosis
| Treatment comparisons | Number of trials | Number of patients | Rebleeding OR (95%CI) | Mortality OR (95%CI) |
| EVL vs sclerotherapy | 20 | 1634 | 0.53 (0.42-0.67) | 0.77 (0.59-0.99) |
| EVL vs NSBBs and IsMn | 4 | 476 | 0.79 (0.62-1.00) | 0.81 (0.61-1.08) |
| EVL vs EVL + NSBBs | 9 | 955 | 0.59 (0.41-0.85) | 0.71 (0.45-1.11) |
| EVL vs EVL + sclerotherapy | 8 | 520 | 1.05 (0.67-1.64) | 0.99 (0.68-1.44) |
| TIPS vs endoscopy | 12 | 883 | 0.32 (0.24-0.43) | 1.17 (0.85-1.61) |
EVL: Endoscopic variceal ligation; IsMn: Isosorbide mononitrate; NSBBs: Non-selective beta-blockers; TIPS: Transjugular intrahepatic portosystemic shunt.